Literature DB >> 1399682

Preparation of 123I-labeled 2'-iodospiperone and imaging of D2 dopamine receptors in the human brain using SPECT.

H Saji1, Y Iida, Y Magata, Y Yonekura, Y Iwasaki, S Sasayama, J Konishi, I Nakatsuka, K Shiba, A Yoshitake.   

Abstract

[123I]2'-ISP was readily prepared using a radioiodine exchange reaction with a radiochemical yield of approx. 50% after HPLC purification. The radiochemical purity of the product was more than 98% and the specific activity was 5.55-11.1 GBq/mumol. Biodistribution studies performed in mice indicated that injection of [123I]2'-ISP with albumin produced a higher gastric uptake and a lower brain uptake than injection of the radioligand in a weakly acidic solution. In addition, toxicity tests performed in mice demonstrated that acute toxic effects would be very unlikely to be encountered if 2'-ISP was used for diagnostic purposes. A preliminary imaging study with [123I]2'-ISP in a healthy human volunteer showed its specific uptake by the basal ganglia, a region of the brain known to have a high density of D2 dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1399682     DOI: 10.1016/0883-2897(92)90147-q

Source DB:  PubMed          Journal:  Int J Rad Appl Instrum B        ISSN: 0883-2897


  2 in total

1.  Myocardial accumulation of a dopamine D2 receptor-binding radioligand, 2'-iodospiperone.

Authors:  H Saji; Y Yonekura; K Tanahashi; Y Iida; Y Iwasaki; Y Magata; J Konishi; A Yokoyama
Journal:  Ann Nucl Med       Date:  1993-08       Impact factor: 2.668

2.  Initial clinical experiences with dopamine D2 receptor imaging by means of 2'-iodospiperone and single-photon emission computed tomography.

Authors:  Y Yonekura; H Saji; Y Iwasaki; T Tsuchida; H Fukuyama; A Shimatsu; Y Iida; Y Magata; J Konishi; A Yokoyama
Journal:  Ann Nucl Med       Date:  1995-08       Impact factor: 2.668

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.